Abbott launches the first and only ready-to-feed liquid infant formula made with whole milk in the U.S. at similar price to its existing Similac powdered formula
Abbott's next-generation Amulet 360 device receives CE Mark to treat people with atrial fibrillation at risk of stroke
Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes
Abbott reaches agreements to resolve a portion of litigation involving its specialty formulas for preterm infants
Abbott and NACHC launch nationwide Food for Health initiative to make nutritious food a core part of healthcare
ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing
New Similac® survey finds social media pressure to be "perfect" is fueling a shift toward authenticity for the next generation of parents
New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health workers
Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes
Goldera Provides Update on 2026 Exploration Programs Targeting Multiple Gold Discovery Opportunities in Ontario and New Brunswick
Nevgold Files NI 43-101 Technical Report For Mineral Resource Estimate on the Limousine Butte Gold-Antimony Project, Nevada
